Dexrazoxane-image1 (Dexrazoxane Image1)
Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-388
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 68083-388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Dexrazoxane-image2 (Dexrazoxane Image2)
This is a clinical trial document showing the number of patients (120) within a treatment group that received FAC/Dexrazoxane or FAC. The graph displays cumulative doses of Doxorubicin (mg/m?) ranging from 350 to 1000+.*
Image3 (Dexrazoxane Image3)
Image4 (Dexrazoxane Image4)
This is a product label for a medicine called AINO. It comes in a single dose via and is for injection only with the active ingredient being Dexrazoxane hydrochloride. It is a sterile, pyrogen-free lyophilized solution that requires reconstitution with sterile water for injection. The reconstituted solution is stable for up to 30 minutes at room temperature or up to 3 hours if refrigerated. The solution should not be administered directly after reconstitution and additional dilution with Lactated Ringer's Injection, USP, is necessary prior to administration via IV drop. Dosage and use instructions are included, and it is important to follow the accompanying prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
